Physician profile
Thomas Rank
NPI 1629366398
$505.79
in general payments reported to CMS, 2019-2025
13 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.22 · 2023: $82.98 · 2024: $144 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $171.99 | 2025 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $67.51 | 2023 | Farxiga |
| Paratek Pharmaceuticals, INC. | $48.88 | 2024-2025 | Nuzyra |
| Csl Behring | $31.93 | 2024 | Kcentra |
| Inspire Medical Systems, INC. | $30.98 | 2024 | Inspire |
| Smith+Nephew, INC. | $30.03 | 2025 | Pico |
| Pfizer INC. | $23.36 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.22 | 2022 | |
| Urgo Medical North America, LLC | $18.99 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medtronic, INC. | $16.50 | 2025 | |
| Tactile Systems Technology INC | $15.65 | 2024 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $15.47 | 2023 | Verquvo |
| Lemaitre Vascular, INC. | $13.28 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.